Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Pilot Diagnostic Accuracy Study (BAKER-DVT)

26 août 2026 mis à jour par: Stig Holm Ovesen, Aarhus University Hospital

Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Feasibility Diagnostic Accuracy Study

Quality improvement study with prospective observational design. The study explores the feasibility of testing diagnostic accuracy of an emergency department-performed focused ultrasound scan of the popliteal fossa in detecting symptomatic Baker's cysts, and to evaluate the potential for such follow-ups to conserve radiological resources. Ultimately, this work aims to establish the feasibility and provide the foundational data necessary for a future definitive diagnostic accuracy study.

Aperçu de l'étude

Description détaillée

Patients with suspected deep vein thrombosis (DVT) are commonly evaluated using clinical probability assessment, D-dimer testing, and compression ultrasonography. However, a substantial proportion of patients referred for DVT evaluation are ultimately diagnosed with alternative conditions that may explain their symptoms. One such condition is a symptomatic Baker's cyst, which may present with unilateral leg pain, swelling, or discomfort that clinically mimics DVT.

In current clinical practice, radiologist-performed complete compression ultrasound of the lower extremity (CCUS) is primarily used to confirm or exclude DVT. Although Baker's cysts are frequently identified during these examinations, their potential role as an early alternative diagnosis within the diagnostic pathway has not been systematically investigated. A focused ultrasound examination of the popliteal fossa (FUP) may allow emergency department (ED) or primary care clinicians to identify symptomatic Baker's cysts before referral for further DVT workup.

This prospective pilot study primarily aims to evaluate the feasibility of conducting a future definitive study investigating the role of FUP in patients with suspected DVT. Key feasibility outcomes include recruitment rates, scan completion rates, workflow integration, procedure timing, and practical implementation within routine emergency care. In addition, the study will generate preliminary diagnostic accuracy estimates regarding the ability of ED physicians and trained research assistants to identify symptomatic Baker's cysts using FUP, with CCUS serving as the reference standard. These data will be used to estimate outcome variance and inform sample size calculations and study design for a future definitive validation study.

This single-center pilot study will be conducted at Aarhus University Hospital, Denmark, among adult patients referred to the ED with suspected DVT. All participants will receive standard diagnostic evaluation and management according to current guidelines. The study-specific FUP examination will be performed before D-dimer and/or CCUS results are available, and FUP findings will not influence clinical decision-making during the study.

Type d'étude

Observationnel

Inscription (Estimé)

150

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Aarhus, Danemark
        • Recrutement
        • Aarhus University Hospital
        • Contact:
          • Stig Holm Ovesen, MD, PhD
          • Numéro de téléphone: 0045 + 29426696
          • E-mail: stigje@rm.dk

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Adult patients referred to the Emergency Department at Aarhus University Hospital with suspected deep vein thrombosis and undergoing diagnostic evaluation with D-dimer testing and/or complete compression ultrasound of the lower extremity will be included consecutively.

La description

Inclusion Criteria:

  • Age ≥ 18 years
  • Clinical signs and symptoms of DVT, prompting the treating physician to initiate d-Dimer or CCUS diagnostic strategies

Exclusion Criteria:

  • Prior inclusion
  • FUP performed following d-Dimer or CCUS result already revealed

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Patients with suspected deep vein thrombosis (DVT)
Adult patients referred to the Emergency Department at Aarhus University Hospital with suspected deep vein thrombosis and undergoing diagnostic evaluation with D-dimer testing and/or complete compression ultrasound of the lower extremity (CCUS) will be included consecutively.
Eligible patients will undergo a focused ultrasound examination of the popliteal fossa performed by a trained research assistant or emergency physician. The examination will be conducted before the results of D-dimer testing and CCUS are available. Operators will assess the presence and characteristics of Baker's cysts, evaluate whether an identified cyst is likely to explain the patient's presenting symptoms, estimate the probability of concurrent DVT, and complete a structured interpretation survey. FUP findings will be recorded for research purposes only and will not influence patient management.
Following FUP, all participants will proceed through the routine diagnostic pathway for suspected DVT. Depending on clinical probability and D-dimer results, patients may undergo no further testing or radiologist-performed complete compression ultrasound of the lower extremity (CCUS) according to standard practice. Final diagnoses established through the routine diagnostic pathway will serve as the reference standard.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Participant recruitment rate
Délai: Immediately after the procedure
Number of eligible patients enrolled per study month and proportion of eligible patients successfully enrolled.
Immediately after the procedure

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Completion rate of Focused Ultrasound of the Popliteal Fossa
Délai: Immediately after the procedure
Proportion of initiated FUP examinations successfully completed and deemed interpretable.
Immediately after the procedure
Duration of the FUP examination
Délai: Immediately after the procedure
Time required to perform and document the FUP examination.
Immediately after the procedure
Diagnostic accuracy of FUP for detection of symptomatic Baker's cysts
Délai: Immediately after the procedure
Sensitivity, specificity, positive predictive value, and negative predictive value of FUP compared with radiologist-performed complete compression ultrasound of the lower extremity (CCUS).
Immediately after the procedure
Frequency of symptomatic Baker's cysts among patients evaluated for suspected DVT.
Délai: Immediately after the procedure
Proportion of participants with a symptomatic Baker's cyst identified on FUP.
Immediately after the procedure
Concurrent DVT in participants with a symptomatic Baker's cyst identified on FUP
Délai: Immediately after the procedure
Proportion of participants with a symptomatic Baker's cyst on FUP who are subsequently diagnosed with DVT through the routine diagnostic pathway.
Immediately after the procedure
Estimated impact of FUP on clinical decision-making
Délai: Immediately after the procedure
Proportion of examinations in which the operator indicates that the FUP finding would have altered the estimated post-test probability of DVT or influenced further diagnostic workup.
Immediately after the procedure
Ultrasound image quality
Délai: Within 60 days of the index examination
Proportion of FUP examinations rated as of adequate diagnostic quality upon retrospective review by a proficient radiologist.
Within 60 days of the index examination

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

3 août 2026

Achèvement primaire (Estimé)

9 octobre 2026

Achèvement de l'étude (Estimé)

9 octobre 2026

Dates d'inscription aux études

Première soumission

24 août 2026

Première soumission répondant aux critères de contrôle qualité

26 août 2026

Première publication (Réel)

27 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

27 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

26 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

The datasets will not be shared due to legal and privacy restrictions associated with data approved for use in a quality improvement study.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner